Changchun GeneScience Pharmaceuticals Co., Ltd. - search

中

EN
中

ADR Reporting

Back to Home

Find 53 Results

Search by column

Search by time

Within one year

[Press Releases] Dr. Lei Jin of GenSci Shines at J.P. Morgan Global China Summit, Sharing Insights on Innovation and Globalization 2026.05.28 >>
[Press Releases] GenSci's Innovative IL-1α/β Bispecific Antibody Receives First FDA Clinical Approval 2026.05.19 >>
[Press Releases] GenSciP166 Selected as Late-Breaking Abstract at SID 2026 2026.05.15 >>
[Press Releases] GenSci's Firsekibart Injection Receives Approval by NMPA 2026.05.07 >>
[Press Releases] GenSci’s NK3R Antagonist for VMS Phase II Study Results Published in Menopause 2026.04.29 >>
[Press Releases] GenSci Presents Multiple Innovative Oncology Pipelines at AACR 2026 2026.04.27 >>
[Press Releases] Positive Phase II Results for GenSci's Firsekibart in Pediatric Rare Disease Published 2026.03.17 >>
[Press Releases] GenSci128, an Investigational Cancer Therapy from Gensci Pharmaceuticals, Receives FDA Orphan Drug Designation for Pancreatic Cancer 2026.03.11 >>

1